FDA Approves Breakthrough New Drug For Hepatitis C – 2nd In Two Weeks

FDA Approves Breakthrough New Drug For Hepatitis C – 2nd In Two Weeks

A new drug to treat hepatitis C that's been hailed as a major breakthrough received FDA approval on Friday, just two weeks after another much-anticipated hepatitis C drug was approved. Sofosbuvir (brand name Sovaldi) is a nucleotide analog inhibitor

5
Like
Save

Comments

Write a comment

*